Neurosurgery News and Research RSS Feed - Neurosurgery News and Research

Insurance status linked to patient safety, quality of care for patients with brain tumors

Insurance status linked to patient safety, quality of care for patients with brain tumors

Patients that are on Medicaid or uninsured have higher rates of reportable patient safety and quality of care issues during hospitalization for brain tumors, reports a study in the March issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
North Memorial Medical Center receives Healthgrades 2015 America's 50 Best Hospitals Award

North Memorial Medical Center receives Healthgrades 2015 America's 50 Best Hospitals Award

Today, North Memorial Medical Center announced that it has received the Healthgrades 2015 America's 50 Best Hospitals Award. The distinction makes North Memorial Medical Center one of the top 1% of more than 4,500 hospitals nationwide for its consistent, year-over-year superior clinical performance as measured by Healthgrades, the leading online resource for comprehensive information about physicians and hospitals. [More]
Filipino women who move to Canada face breast cancer risk at younger age

Filipino women who move to Canada face breast cancer risk at younger age

Filipinos who move to Canada are diagnosed with breast cancer at a younger age than women from other parts of East Asia or Caucasians, new research has found. [More]
Discoveries by WA research team offer further treatment hope for victims of stroke

Discoveries by WA research team offer further treatment hope for victims of stroke

A West Australian research team has made a series of discoveries which may help to minimise the damage that a stroke can cause. [More]
Study results pave way for new clinical trial for glioblastoma patients

Study results pave way for new clinical trial for glioblastoma patients

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research. [More]
Study suggests introduction of specific NGF to prevent neuronal degradation in Alzheimer's patients

Study suggests introduction of specific NGF to prevent neuronal degradation in Alzheimer's patients

Scientists at Karolinska Institutet have evaluated a new Alzheimer's therapy in which the patients receive an implant that stimulates the growth of a certain type of nerve cell. The results, which are published in the scientific journal Alzheimer's & Dementia, suggest that the introduction of a nerve growth factor can prevent neuronal degradation in Alzheimer's patients. [More]
MJC ICM works out general guidelines for intensive care medicine

MJC ICM works out general guidelines for intensive care medicine

Frankfurt-based intensive care medical practitioner, Kai Zacharowski, is working on a joint curriculum for Europe. [More]
Researchers create new intraoperative probe for detecting cancer cells

Researchers create new intraoperative probe for detecting cancer cells

Brain cancer patients may live longer thanks to a new cancer-detection method developed by researchers at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC, and Polytechnique Montréal. [More]
Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Retigabine drug shows promise in protecting the brain against effects of ischemic stroke

Retigabine, a drug approved to treat epilepsy, protected the brain against the effects of ischemic stroke in a study conducted at The University of Texas Health Science Center at San Antonio. [More]
Opioid withdrawal in Ontario newborns increases 15-fold

Opioid withdrawal in Ontario newborns increases 15-fold

The number of newborns suffering from opioid withdrawal increased 15-fold in Ontario over 20 years, according to research published today in CMAJ Open. [More]
Experts question use of hospital quality measures in CMS’ pay-for-performance programs

Experts question use of hospital quality measures in CMS’ pay-for-performance programs

A new editorial published in JAMA by Northwestern Medicine® experts strongly questions the use of several hospital quality measures by the Centers for Medicare & Medicaid Services (CMS) in its pay-for-performance programs. [More]
New research provides hope for treating stroke using HUCBCs

New research provides hope for treating stroke using HUCBCs

Researchers have known that transplanted human umbilical cord cells (HUCBCs) can have a restorative effect on the brain and brain function following a stroke. However, just how the cells exert their therapeutic effects has not been clear. Now, a research team from the University of South Florida using animal models of stroke has found that the HUCBCs are most beneficial in preventing neuron loss when the Akt signaling pathway is activated by secretions from the HUCBCs and that Akt activation subsequently impacts a specific gene involved in reducing inflammation. [More]
Japanese researchers explore use of bone marrow transplants to treat hypophosphatasia

Japanese researchers explore use of bone marrow transplants to treat hypophosphatasia

Recent research carried out by a team of researchers in Japan has investigated the use of bone marrow transplants (BMTs) to treat hypophosphatasia (HPP). In this study, the researchers carried out BMT for two infants with HPP in combination with allogenic (other-donated) mesenchymal stem cell transplants (MSCTs). The allogenic MSC donors were a parent of the infant. [More]
Drugs designed to target NHE9 protein could help fight glioblastoma

Drugs designed to target NHE9 protein could help fight glioblastoma

Applying lessons learned from autism to brain cancer, researchers at The Johns Hopkins University have discovered why elevated levels of the protein NHE9 add to the lethality of the most common and aggressive form of brain cancer, glioblastoma. Their discovery suggests that drugs designed to target NHE9 could help to successfully fight the deadly disease. [More]
New study shows that 25% of homeless people in Toronto have vision problems

New study shows that 25% of homeless people in Toronto have vision problems

Twenty-five per cent of homeless people surveyed in Toronto had vision problems up to and including blindness, four times higher than the rate of the overall population in North America, a new study by St. Michael's Hospital has found. [More]
Retigabine drug could reduce debilitating impact of strokes

Retigabine drug could reduce debilitating impact of strokes

New research suggests that an already-approved drug could dramatically reduce the debilitating impact of strokes, which affect nearly a million Americans every year. [More]
Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Northwestern Medicine researchers evaluate unique surgical method to treat chronic amputee pain

Northwestern Medicine® researchers are leading a new multi-center clinical trial to evaluate a unique surgical method, known as targeted muscle reinnervation (TMR), to treat chronic pain that can result from limb amputation. Around a quarter of all amputees develop chronic pain in the remaining portion of their amputated limb, which can include phantom limb syndrome (pain that is perceived in the portion of the limb that is gone), and prevents many patients from using prostheses. [More]
Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Johns Hopkins researchers successfully deliver new nanoparticle gene therapy to treat glioma in rats

Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain. [More]
Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the second quarter of fiscal 2015, ended December 31, 2014. [More]
Two new fluorescent dyes may help localize, resect brain tumors

Two new fluorescent dyes may help localize, resect brain tumors

Two new fluorescent dyes attracted to cancer cells may help neurosurgeons more accurately localize and completely resect brain tumors, suggests a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
Advertisement